FlyBase Human Disease Model Report Index
- 3-methylglutaconic aciduria
- 46,XX sex reversal 4
- 46,XY gonadal dysgenesis (postulated), STARD8-related
- acute myeloid leukemia
- acyl-CoA dehydrogenase, medium chain, deficiency of
- Adams-Oliver syndrome 3
- adenoid cystic carcinoma, multigenic, personalized
- adrenoleukodystrophy, ABCD1-related
- adrenoleukodystrophy (postulated), ACSBG-related
- advanced sleep phase syndrome
- age-dependent ectopic fat accumulation, HDAC6-related
- Alexander disease
- alcohol use disorder, susceptibility to (fly models overview)
- alcohol, developmental effects
- alcohol, increased aggressive behavior
- alcohol, response to, actin-mediated
- alcohol, response to, AKAP-related
- alcohol, response to, ARF6-related
- alcohol, response to, ATG16L-related
- alcohol, response to, AUTS2-related
- alcohol, response to, cathepsin-related
- alcohol, response to, CBP-related
- alcohol, response to, circadian genes
- alcohol, response to, Crz neuropeptide-related
- alcohol, response to, Dmel_apt-related
- alcohol, response to, dopamine receptor DRD1,5-related
- alcohol, response to, dual-GPCR signaling
- alcohol, response to, EGFR-MAPK/ERK signaling
- alcohol, response to, EPS8-related
- alcohol, response to, F-actin turnover-related
- alcohol, response to, GABBR-related
- alcohol, response to, GRK4,5,6-related
- alcohol, response to, GSTO-related
- alcohol, response to, HOMER-related
- alcohol, response to, INSR-related
- alcohol, response to, insulin signaling pathway
- alcohol, response to, JmjC-domain-containing genes
- alcohol, response to, KCNMA1-related
- alcohol, response to, learning and memory genes
- alcohol, response to, MAP4K-related
- alcohol, response to, MEF2-related
- alcohol, response to, microRNA-related
- alcohol, response to, NMDA-receptor-mediated
- alcohol, response to, NPY-related
- alcohol, response to, PI3K-AKT signaling pathway
- alcohol, response to, PSD-related
- alcohol, response to, RhoGAP-related
- alcohol, response to, RPS6KB-related
- alcohol, response to, RSU1-related
- alcohol, response to, RYR-related
- alcohol, response to, stress-response genes
- alcohol, response to, SIRT1-related
- alcohol, response to, SLC39A8-related
- alcohol, response to, UNC13A-related
- alcohol, response to, XRCC5-related
- persistent alcohol cue memory
- Alpers-Huttenlocher syndrome
- alpha-1-antitrypsin deficiency
- Alzheimer disease
- Alzheimer disease 1
- Alzheimer disease 2
- Alzheimer disease, APP-BACE1-related
- Alzheimer disease, presenilin-related
- Alzheimer disease, retromer dysfunction
- Alzheimer disease, susceptibility to, CD2AP-related
- Alzheimer disease, susceptibility to, FERMT2-related
- Alzheimer disease, susceptibility to, PICALM-related
- Alzheimer disease, susceptibility to, TOMM40-related
- Alzheimer disease, susceptibility to (postulated), CELF1-related
- Alzheimer disease, susceptibility to (postulated), GCAT-related
- Alzheimer disease, susceptibility to (postulated), ITGAM-ITGA9-related
- Alzheimer disease, susceptibility to (postulated), MAST4-related
- Alzheimer disease, susceptibility to (postulated), NCSTN-related
- Alzheimer disease, susceptibility to (postulated), PLD3-related
- Alzheimer disease, susceptibility to (postulated), PTPRD-related
- Alzheimer disease, susceptibility to (postulated), SLC2A14-related
- Alzheimer disease, susceptibility to (postulated), SNRPN-related
- Alzheimer disease, susceptibility to (postulated), TM2D3-related
- Alzheimer disease, susceptibility to (postulated), XYLT1-related
- amyloidosis, hereditary systemic
- amyotrophic lateral sclerosis
- anesthesia, response and mechanisms
- Angelman syndrome
- anxiety modulators, fly wall-following model
- anxiety modulator(s), serotonin class 2 receptor(s)
- anxiety modulator(s), genes affecting actin filament stability
- anxiety modulator(s), CCK-like receptors
- ARC syndrome
- arrhythmogenic right ventricular dysplasia 5
- arthrogryposis, distal
- Aspergillus species infection
- asthma, susceptibility to, ORMDL3-related
- ataxia-oculomotor apraxia 1
- ataxia-telangiectasia
- ataxia-telangiectasia-like disorder 1
- atrial septal defect
- attention deficit hyperactivity disorder, susceptibility to
- attention deficit hyperactivity disorder, susceptibility to (postulated), ADGRL3-related
- attention deficit hyperactivity disorder, susceptibility to (postulated), FBXO25-related
- attention deficit hyperactivity disorder, susceptibility to (postulated), MEF2C-related
- attention deficit hyperactivity disorder, susceptibility to (postulated), SLC6A3-related
- attention deficit hyperactivity disorder, susceptibility to (postulated), TRAPPC9-related
- attention deficit hyperactivity disorder, susceptibility to (postulated), VPS4A-related
- auditory neuropathy, autosomal dominant 1
- autism co-occurence with schizophrenia
- autism spectrum disorder, susceptibility to
- autism, environmental risk, exposure to bisphenols
- autism spectrum disorder, susceptibility to, AGAP1-related
- autism spectrum disorder, susceptibility to, ASH1-related
- autism spectrum disorder, susceptibility to, CHD1,2-related
- autism spectrum disorder, susceptibility to, CHD6-9-related
- autism spectrum disorder, susceptibility to, CSDE1-related
- autism spectrum disorder, susceptibility to, de novo coding mutations (postulated)
- autism spectrum disorder, susceptibility to, KDM5-related
- autism spectrum disorder, susceptibility to, NBEA-related
- autism spectrum disorder, susceptibility to, NLGN-related
- autism spectrum disorder, susceptibility to, NRXN-related
- autism spectrum disorder, susceptibility to, RIMS-related
- autism spectrum disorder, susceptibility to, SHANK-related
- autism spectrum disorder, susceptibility to, SLC9A6,9-related
- autism spectrum disorder, susceptibility to, TSC1-related
- autism spectrum disorder, susceptibility to, UBE3A-related
- autism spectrum disorder, susceptibility to, WDFY3,4-related
- autism spectrum disorder, susceptibility to (postulated), ABCA-related
- autism spectrum disorder, susceptibility to (postulated), MAPK3-related
- autism spectrum disorder, susceptibility to (postulated), NDST-related
- autism spectrum disorder, susceptibility to (postulated), SLC6A3-related
- autism spectrum disorder, susceptibility to (postulated), TAOK2-related
- autism spectrum disorder, susceptibility to (postulated), TOP3B-related
- autism spectrum disorder, susceptibility to (postulated), TRPC6-related
- autism spectrum disorder with intellectual disability and seizures (postulated), SCAMP5-related
- White-Sutton syndrome
- azoospermia, non-obstructive
- azoospermia, Sertoli-cell-only syndrome, DDX3-related
- azoospermia (postulated), CDC42BPA-related
- azoospermia (postulated), DMRT2-related
- azoospermia (postulated), ESRRB-ESRRG-related
- azoospermia (postulated), NDST1-related
- azoospermia (postulated), PTPRD-related
- azoospermia (postulated), SNRPA1-related
- azoospermia (postulated), TDRKH-related
- azoospermia (postulated), YIPF5-related
- azoospermia (postulated), ZNF622-related
- azoospermia and testicular germ cell cancer (postulated), FOXN3-related
- azoospermia associated with Bardet-Biedl syndrome, SCAPER-related
- spermatogenic failure, X-linked, 9
- Barth syndrome
- basal cell carcinoma, SMO-related
- Becker muscular dystrophy
- Birt-Hogg-Dube syndrome
- Bloom syndrome
- Boucher-Neuhauser syndrome
- brachycephaly, trichomegaly, and developmental delay
- branchiootorenal spectrum disorders, EYA1-related
- Brown-Vialetto-Van Laere syndrome 1
- Brown-Vialetto-Van Laere syndrome 2
- Brunet-Wagner neurodevelopmental syndrome
- calcium-induced neurotoxicity, TRP-channel-related
- cancer, general (fly models overview)
- acute myeloid leukemia
- adenoid cystic carcinoma, multigenic, personalized
- azoospermia and testicular germ cell cancer (postulated), FOXN3-related
- basal cell carcinoma, SMO-related
- cachexia, IGFBP-related
- cachexia, RAS-SCRIB larval model
- cachexia, yki-induced eye tumor model
- cachexia, yki-induced ISC tumor model
- cancer, aerobic glycolysis (Warburg effect), larval growth model
- cancer, epithelial, ABL-related
- cancer, epithelial, AFDN-SCRIB-related
- cancer, epithelial, ALG3-related
- cancer, epithelial, compromised apoptosis
- cancer, epithelial, compromised apoptosis and cell-cycle checkpoint defects
- cancer, epithelial, compromised apoptosis and DNA repair defects
- cancer, epithelial, DLG1-related
- cancer, epithelial, DST-related
- cancer, epithelial, EGFR-related
- cancer, epithelial, EGFR-Dmel_psq model
- cancer, epithelial, EGFR-Hippo-signaling
- cancer, epithelial, EGFR-HSPG2 related
- cancer, epithelial, EGFR-microRNA-related
- cancer, epithelial, EGFR-SOCS-related
- cancer, epithelial, ESCRT-complexes-related
- cancer, epithelial, glycolytic tumor model
- cancer, epithelial, ING1-related
- cancer, epithelial, LLGL-related
- cancer, epithelial, LLGL-MYC-related
- cancer, epithelial, LLGL-YAP1-related
- cancer, epithelial, Notch signaling, Hedgehog signaling
- cancer, epithelial, NOTCH-LLGL-related
- cancer, epithelial, NOTCH-SCRIB-related
- cancer, epithelial, Par-complex-related
- cancer, epithelial, RAB5-microRNA-related
- cancer, epithelial, RAF-Hippo-signaling
- cancer, epithelial, RAF-SCRIB-related
- cancer, epithelial, RAS models, role of autophagy
- cancer, epithelial, RAS-ATP6V-related
- cancer, epithelial, RAS-DLG1-related
- cancer, epithelial, RAS-Hippo-signaling
- cancer, epithelial, RAS-LLGL-related
- cancer, epithelial, RAS-PAXIP1/TP53-related
- cancer, epithelial, RAS-SCRIB-related
- cancer, epithelial, RAS-STK11-related
- cancer, epithelial, RAS-TSPAN-related
- cancer, epithelial, RPS6KA3-related
- cancer, epithelial, SALL4-related
- cancer, epithelial, SCRIB-hyperinsulinemia model
- cancer, epithelial, SCRIB-LATS1,2-related
- cancer, epithelial, SCRIB-MAPK1,3-related
- cancer, epithelial, SCRIB-related
- cancer, epithelial, SCRIB-YAP1-related
- cancer, epithelial, SCRIB-ZBTB(TF)-related
- cancer, epithelial, Scribble-complex-related
- cancer, epithelial, SRC,CSK-related
- cancer, epithelial, STAG1,2-related
- cancer, epithelial, STX7,12-related
- cancer, epithelial, TNF-DLG1-related
- cancer, epithelial, TNF-RAS-related
- cancer, epithelial, TNF-SCRIB-related
- cancer, epithelial, TNF-SCRIB-RAS-related
- cancer, epithelial, Toll-receptor-related
- cancer, gastrointestinal, susceptibility due to H. pylori infection
- cancer, germline stem cell models
- cancer, inherited susceptibilities to
- cancer, intercellular interactions, RAS-mito
- cancer, intercellular interactions, RAB5-related
- cancer, intercellular interactions, SRC-related
- cancer, intestinal dysplasia, UVRAG-related
- cancer, intestinal stem cell models
- cancer, intestinal stem cell, APC-RAS-related
- cancer, intestinal stem cell, APC-RAS-SNA-related
- cancer, intestinal stem cell, EGFR-related
- cancer, intestinal stem cell, NOTCH-related
- cancer, intestinal stem cell, RAS-NOTCH-related
- cancer, intestinal stem cell, RAS-related
- cancer, intestinal stem cell (postulated), SNX9,18,33-related
- cancer, intestinal stem cell, SRC-related
- cancer, ISC, intercellular feedback loop, SOX-related
- cancer, intestinal, impact of Pseudomonas aeruginosa infection
- cancer, invasive collective cell migration, border cell model
- cancer, malignant glioma, AURKA/WDR62-related
- cancer, malignant glioma, EGFR-related
- cancer, malignant glioma, EGFR-MYC-related
- cancer, malignant glioma, EGFR-PIK3C-related
- cancer, malignant glioma, FGFR-TACC fusion
- cancer, malignant glioma, H3-3A-related
- cancer, malignant glioma, Par-complex-related
- cancer, malignant glioma, RAS model
- cancer, malignant glioma, RAS-PTEN-related
- cancer, Malpighian tubule stem cell
- cancer, mesothelial, FMR1-related
- cancer, models of chromosomal instability
- cancer, multiple, actin-remodeling regulators
- cancer, multiple, ALK-related
- cancer, multiple, apoptosis-induced proliferation
- cancer, multiple, AXIN-related
- cancer, multiple, BRAF-related
- cancer, multiple, CCR4-NOT complex
- cancer, multiple, CTNNB1-related
- cancer, multiple, epigenetic mechanisms
- cancer, multiple, germline-specific genes
- cancer, multiple, Hedgehog signaling pathway
- cancer, multiple, HIPK-related
- cancer, multiple, Hippo signaling pathway
- cancer, multiple, IDH1,2-related
- cancer, multiple, JAG-microRNA-related
- cancer, multiple, MAP2K1,2-related
- cancer, multiple, MAPK1,3-related
- cancer, multiple, MYC-related
- cancer, multiple, modulation by steroid hormone via mir-let7
- cancer, multiple, NEK2-RAS-CSK(SRC)-related
- cancer, multiple, NEK2-RET-related
- cancer, multiple, Notch signaling pathway
- cancer, multiple, NOTCH-MEF2-related
- cancer, multiple, NOTCH-PI3K-AKT-related
- cancer, multiple, NOTCH-SRC-related
- cancer, multiple, PI3K-AKT signaling pathway
- cancer, multiple, RAF-RHOGEF-related
- cancer, multiple, RAF1-related
- cancer, multiple, RAS with actin regulators
- cancer, multiple, RAS-related
- cancer, multiple, RAS-CSK(SRC)-related
- cancer, multiple, RAS-CSK(SRC)-related with high-sugar diet
- cancer, multiple, RAS-RHOGEF-related
- cancer, multiple, RAS-S100A4-related
- cancer, multiple, RAS-SRC-related
- cancer, multiple, RAS-Vps-C complex-related
- cancer, multiple, regulators of necrosis
- cancer, multiple, RET fusions
- cancer, multiple, TET2-related
- cancer, multiple, TP53-related
- cancer, multiple, TP53-MYC-related
- cancer, multiple, UBIAD1-related
- cancer, multiple, WWOX-related
- cancer, neural stem cell, AFDN-SCRIB-related
- cancer, neural stem cell, centrosome dysfunction
- cancer, neural stem cell, disruption of asymmetric division
- cancer, neural stem cell, HES (bHLH TF)-related
- cancer, neural stem cell, LLGL-related
- cancer, neural stem cell, L3MBTL-related
- cancer, neural stem cell, Notch-related
- cancer, neural stem cell, NR2E1-related
- cancer, neural stem cell, retromer tumor suppressors
- cancer, neural stem cell, TRIM2,3-related
- cancer, neural stem cell dedifferentiation
- cancer, sarcoma, CIC-DUX4 fusion
- cancer, tracheal model of angiogenesis
- cancer therapeutic, Drosophila deoxyribonucleoside kinase
- colorectal cancer
- colorectal cancer, personalizable in silico model
- Ewing sarcoma
- familial adenomatous polyposis
- gastric cancer, hereditary diffuse, CDH1-related
- gastric cancer, TPM4-ALK fusion
- hematologic cancer (fly models overview)
- HPV-related carcinoma, E5-E6-E7-UBE3A models
- juvenile polyposis syndrome, TGF-beta/BMP signaling pathway
- Li-Fraumeni syndrome 1
- lung cancer, adenocarcinoma, KIF5B-RET fusion
- lung cancer, RAS-PTEN-related
- multiple endocrine neoplasia
- multiple myeloma, DIS3-related
- myeloproliferative disorders, JAK2-related
- neuroblastoma, susceptibility to, 3
- ovarian carcinoma, RAS-PKRC-related
- pancreatic carcinoma, multigenic
- pituitary adenoma 1, multiple types
- prostate cancer
- rhabdoid tumor predisposition syndrome 1
- rhabdomyosarcoma 2, PAX7-FOXO1 fusion
- rhabdomyosarcoma 2, PAX3-FOXO1 fusion
- schwannomatosis, vestibular
- SETD2-related diseases
- thyroid carcinoma, familial medullary
- thyroid carcinoma, nonmedullary
- von Hippel-Lindau syndrome
- Candida species infection
- cardiac dysfunction (fly models overview)
- cardiac arrhythmias
- cardiac dysfunction, COX-2 inhibitor-induced
- cardiac dysfunction, tumor-induced
- cardiac dysfunction (postulated), CCR4-NOT complex
- cardiac dysfunction (postulated), CRLS1-related
- cardiac dysfunction (postulated), PYGO-related
- cardiac dysfunction (postulated), SOX5-related
- cardiac dysfunction (postulated), SPARC-related
- cardiac dysfunction (postulated), talin-related
- cardiac dysfunction (postulated), TRiC/CCT complex
- cardiomyopathy
- arrhythmogenic right ventricular dysplasia 5
- cardiomyopathy, familial hypertrophic
- cardiomyopathy, familial hypertrophic 1
- cardiomyopathy, familial hypertrophic 2
- cardiomyopathy, familial hypertrophic 3
- cardiomyopathy, familial hypertrophic 4
- cardiomyopathy, familial hypertrophic 7
- cardiomyopathy, familial hypertrophic 10
- cardiomyopathy, familial hypertrophic 11
- cardiomyopathy, familial hypertrophic 14
- cardiomyopathy, familial hypertrophic 15
- cardiomyopathy, familial hypertrophic 17
- cardiomyopathy, familial hypertrophic 18
- cardiomyopathy, familial hypertrophic 26
- cardiomyopathy, hypertrophic (postulated), EGFR/ERBB-related
- cardiomyopathy, hypertrophic (postulated), profilin-related
- cardiomyopathy, hypertrophic (postulated), RAF-related
- cardiomyopathy, hypertrophic (postulated), RAS-related
- cardiomyopathy, familial restrictive
- cardiomyopathy induced by nephrocyte loss/dysfunction
- cardiomyopathy, MYBPC3-related
- cardiomyopathy, MYH6-MYH7-related
- cardiomyopathy, PLN-related
- cardiomyopathy (postulated), calcineurin-A-related
- cardiomyopathy (postulated), SOCE-related
- cardiomyopathy (postulated), translation-critical genes
- cardiomyopathy, TNNI3-related
- cardiomyopathy, TNNT2-related
- cardiomyopathy, TPM1-related
- cardiomyopathy, VCL-related
- dilated cardiomyopathy
- high-fat diet, cardiomyopathy
- high-sugar diet, cardiomyopathy
- lipotoxic cardiomyopathy, ceramide/sphingolipid-related
- muscle and aortic defects, ARIH1-related
- cardiac function, response to hypoxia
- cardiofaciocutaneous syndrome
- cataract 48, infantile-onset
- CEDNIK syndrome
- centronuclear myopathy
- cerebellar atrophy, visual impairment, and psychomotor retardation
- cerebral amyloid angiopathy
- cerebral cavernous malformations 3
- cerebral palsy, spastic quadriplegic
- Charcot-Marie-Tooth disease
- Charcot-Marie-Tooth disease, axonal, type 2DD
- Charcot-Marie-Tooth disease, axonal, type 2EE
- Charcot-Marie-Tooth disease, axonal, type 2KK
- Charcot-Marie-Tooth disease, axonal, type 2L
- Charcot-Marie-Tooth disease, axonal, type 2O
- Charcot-Marie-Tooth disease, dominant intermediate B
- Charcot-Marie-Tooth disease, dominant intermediate C
- Charcot-Marie-Tooth disease, dominant intermediate E
- Charcot-Marie-Tooth disease, GDAP1-related
- Charcot-Marie-Tooth disease, INSC-related
- Charcot-Marie-Tooth disease, MFN2-related
- Charcot-Marie-Tooth disease, RAB40B-related
- Charcot-Marie-Tooth disease, recessive intermediate D
- Charcot-Marie-Tooth disease, type 2B
- Charcot-Marie-Tooth disease, type 2D
- Charcot-Marie-Tooth disease, type 2T
- Charcot-Marie-Tooth disease, type 4B1
- Charcot-Marie-Tooth disease, type 4J
- Charcot-Marie-Tooth disease (postulated), SGPL1-related
- neuropathy, hereditary motor and sensory, type IIC
- CHARGE syndrome, CHD7-related
- Chediak-Higashi syndrome
- chorea-acanthocytosis
- choroideremia
- chromosome 3q29 deletion syndrome
- chromosome 15q11.2 deletion syndrome
- chromosome 16p11.2 deletion syndrome, 593-kb
- chromosome 22q11.2 deletion syndrome
- chronic inflammatory lung disease
- chronic myeloid leukemia, BCR-ABL1 fusions
- ciliary dyskinesia, primary
- CODAS syndrome
- coenzyme Q10 deficiency, primary
- Coffin-Lowry syndrome
- Coffin-Siris syndrome
- cognitive/behavioral disorders, PRODH-related
- cognitive disorders, diet-induced
- cognitive impairment, drug-induced
- colorectal cancer
- combined D-2- and L-2-hydroxyglutaric aciduria
- combined oxidative phosphorylation deficiency
- combined saposin deficiency
- cone-rod dystrophy
- congenital disorder of deglycosylation 1
- congenital disorders of glycosylation, type I
- congenital disorders of glycosylation, type II
- congenital heart defect
- atrial septal defect
- congenital heart defect (postulated), CHD7-related
- congenital heart defect (postulated), EIF4G3-related
- congenital heart defect (postulated), KMT2-related
- congenital heart defect (postulated), LRP2-related
- congenital heart defect (postulated), METTL23-related
- congenital heart defect (postulated), PSMD7-related
- congenital heart defect (postulated), RPL13-related
- congenital heart defect (postulated), RPL14-related
- congenital heart defect (postulated), RPS24-related
- congenital heart defect (postulated), SREBF1-related
- congenital heart defect (postulated), UBB-related
- congenital heart defect (postulated), UBE2B-related
- congenital heart defect (postulated), WDR5-related
- congenital heart defect (postulated), KIF1A-related
- hypoplastic left heart syndrome (postulated), CHCHD3,6-related
- congenital myasthenic syndrome
- copper metabolism disorders, ATP7-related
- copper metabolism disorder (postulated), SLC31A-related
- Cornelia de Lange syndrome
- cortical dysplasia, complex, with other brain malformations 13
- cortical dysplasia, complex, with other brain malformations 15
- Costello syndrome
- Cowden syndrome 1
- Creutzfeldt-Jakob disease, familial
- cystic fibrosis, gastrointestinal pathologies
- cystic fibrosis-like, miRNA-mediated ENaC dysregulation
- cystic renal dysplasia, susceptibility to, BICC1-related
- D-2-hydroxyglutaric aciduria
- Darier-White disease
- deafness and hearing loss (fly models overview)
- Dent disease 1
- dentatorubral-pallidoluysian atrophy
- depression-like behaviors, drug-induced
- depression-like behaviors, stress-induced
- depression-like behaviors (postulated), MIR184-related
- DeSanto-Shinawi syndrome
- developmental and epileptic encephalopathy
- developmental delay and seizures, FARS2-related
- developmental delay, dysmorphic facies, and brain anomalies
- diabetes mellitus, insulin-dependent (type 1) (fly models overview)
- diabetes mellitus, insulin-resistant, with acanthosis nigricans
- diabetes mellitus, noninsulin-dependent (type 2) (fly models overview)
- diabetes mellitus type 2, environmental toxin-induced
- diabetes mellitus type 2, susceptibility to, AKT-related
- diabetes mellitus type 2, susceptibility to, HHEX-related
- diabetes mellitus type 2, susceptibility to, IGF2BP-related
- diabetes mellitus type 2, susceptibility to, IRS1,2-related
- diabetes mellitus type 2, susceptibility to (postulated), AFF2-related
- diabetes mellitus type 2, susceptibility to (postulated), BCL11A-related
- diabetes mellitus type 2, susceptibility to (postulated), GLIS3-related
- diabetes mellitus type 2, susceptibility to (postulated), UCHL1-related
- diabetes/obesity, impact of parental disease
- glucose metabolism disease, GCK-related
- high-fat diet, insulin pathway effects
- high-protein diet, insulin pathway effects
- high-sugar diet, adipokinetic hormone signaling
- high-sugar diet, insulin pathway effects
- insulin pathway effects, BMP/TGFB-related
- insulin pathway effects, decretin-related
- insulin pathway effects, DGK-related
- insulin pathway effects, FMR1-related
- insulin pathway effects, IDE-related
- insulin pathway effects, mechanical stress requirement
- insulin pathway effects, MIR137/PTPN1,2-related
- insulin pathway effects, MYORG-related
- insulin pathway effects, NUDT-related
- insulin pathway effects, PIK3C-related
- insulin pathway effects, RHEB-related
- insulin pathway effects, RPS6KB-related
- insulin pathway effects, SIRT1-related
- insulin pathway effects, TMEM18-related
- insulin pathway effects, TRIB-related
- insulin resistance syndromes, INSR-related
- insulin signaling, regulation of fat storage, Drosophila fat body model
- maturity-onset diabetes of the young, type 1
- diabetes mellitus, pathogenic impact, glyoxalase function
- diabetes/obesity, impact of parental disease
- diabetic neuropathy
- Donohue syndrome
- DOORS syndrome
- Down syndrome
- drug discovery and assessment (fly models overview)
- Duchenne muscular dystrophy
- DYNC1H1-related neurodevelopmental and neuromuscular disorders
- DYRK1A-related intellectual disability syndrome
- dyskeratosis congenita
- dyskinesia, drug-induced
- dystonia
- EAST syndrome
- Ehlers-Danlos syndrome
- encephalopathy due to defective mitochondrial and peroxisomal fission 1
- encephalopathy, familial, with neuroserpin inclusion bodies
- encephalopathy, hypotonia and developmental delay, OXA1L-related
- encephalopathy, neonatal severe, MECP2-related
- encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum
- epidermolysis bullosa simplex, keratin-related
- epilepsy
- developmental and epileptic encephalopathy
- epilepsy, chemically-induced
- epilepsy, early-onset
- epilepsy, familial adult myoclonic
- epilepsy, familial focal, with variable foci
- epilepsy, focal (postulated), UNC13B-related
- epilepsy, generalized, with febrile seizures plus
- epilepsy, idiopathic generalized
- epilepsy, nocturnal frontal lobe, 5
- epilepsy, photosensitive, sphingolipid/sphingomyelin-related
- epilepsy, PRICKLE-related
- epilepsy, progressive myoclonic
- epilepsy, refractory, SCN-alpha-ABCC1 model
- epilepsy, rolandic, with paroxysmal exercise-induced dystonia
- epilepsy, SCN-alpha-related
- developmental and epileptic encephalopathy, 6
- developmental and epileptic encephalopathy, 11
- developmental and epileptic encephalopathy, 13
- epilepsy, generalized, with febrile seizures plus, type 2
- epilepsy, generalized, with febrile seizures plus, type 7
- seizures, benign familial infantile, 3
- epilepsy, SLC12A5-related
- Kohlschutter-Tonz syndrome
- mitochondrial disease with seizure-sensitivity and hearing loss (postulated), MRPS12-related
- myoclonic-atonic epilepsy
- seizures, benign familial infantile
- seizure-sensitive (postulated), ETNK-related
- seizure-sensitive (postulated), SLC12A1-3-related
- seizure-sensitive (postulated), SLC24A-related
- seizure-sensitive, potassium channel defects (eag, Sh model)
- seizure-sensitive, potassium channel defects, KCNT1-2-related
- seizure sensitive/resistant (postulated), PRKG1-related
- seizure sensitivity, disruption during critical developmental period
- seizure-sensitivity model, Dmel_jus
- episodic ataxia
- episodic kinesigenic dyskinesia, KCNJ10-related
- Epstein-Barr virus infection
- erythrokeratodermia variabilis et progressiva 1
- Escherichia coli infection
- essential tremor, hereditary
- Ewing sarcoma
- Fabry disease
- familial adenomatous polyposis
- Fanconi anemia
- Fanconi renotubular syndrome 4 with MODY
- fascioscapulohumeral muscular dystrophy 1
- fascioscapulohumeral muscular dystrophy, FRG1-related
- fatal familial insomnia
- fibrodysplasia ossificans progressiva
- fibrosis, pericellular accumulation of collagen IV
- flavivirus infection (dengue, West Nile, Zika)
- Fliedner-Zweier syndrome
- focal segmental glomerulosclerosis
- fragile-X-related syndromes
- Friedreich ataxia 1
- frontotemporal dementia
- frontotemporal dementia and/or amyotrophic lateral sclerosis 1
- frontotemporal dementia and/or amyotrophic lateral sclerosis 2
- frontotemporal dementia and/or amyotrophic lateral sclerosis 3
- frontotemporal dementia and/or amyotrophic lateral sclerosis 4
- frontotemporal dementia and/or amyotrophic lateral sclerosis 6
- frontotemporal dementia and/or amyotrophic lateral sclerosis 7
- frontotemporal dementia and/or amyotrophic lateral sclerosis, TAF15-related
- galactosemia
- Galloway-Mowat syndrome 3
- GAND syndrome
- gastric cancer, hereditary diffuse, CDH1-related
- gastric cancer, TPM4-ALK fusion
- Gaucher disease, GBA1-related
- genotoxicity studies (fly models overview)
- geroderma osteodysplastica
- Gerstmann-Straussler disease
- glaucoma
- global developmental delay and congenital ataxia, CACNA1A-related
- global developmental delay with impaired intellectual development, hypotonia, and seizures, CAPZA2-related
- glucose metabolism disease, GCK-related
- glycerol kinase deficiency
- glycogen accumulation disorders, GYS1 model
- glycogen storage disease III
- glycogen storage disease IXa
- GPKOW-associated multisystemic disorder
- Guillouet-Gordon syndrome
- Harel-Yoon syndrome
- Halperin-Birk syndrome
- hematologic cancer (fly models overview)
- Hengel-Maroofian-Schols syndrome
- Hennekam lymphangiectasia-lymphedema syndrome 2
- Hermansky-Pudlak syndrome
- HIBCH deficiency
- high-fat diet, cardiomyopathy
- high-fat diet, insulin pathway effects
- high-fat diet, kidney disease
- high-fat diet, obesity
- high-protein diet, insulin pathway effects
- high-salt diet, locomotor and cardiac dysfunction
- high-starch diet, obesity
- high-sugar diet, adipokinetic hormone signaling
- high-sugar diet, cardiomyopathy
- high-sugar diet, insulin pathway effects
- high-sugar diet, nephropathy
- high-sugar diet, obesity
- high-sugar diet, retinopathy
- Hirschsprung disease, susceptibility to, 1
- histiocytosis-lymphadenopathy plus syndrome
- HIV infection
- homocystinuria due to cystathionine beta-synthase deficiency
- HPV-related carcinoma, E5-E6-E7-UBE3A models
- HSD10 mitochondrial disease
- HTLV-1-induced adult T-cell leukemia/lymphoma
- Huntington disease
- Huntington disease-like 2
- Hutchinson-Gilford progeria syndrome
- hydrolethalus syndrome 1
- hyperoxaluria, primary
- hyperprolinemia, type II
- hypervalinemia and hyperleucine-isoleucinemia
- hypoparathyroidism, familial isolated
- hypoparathyroidism-retardation-dysmorphism syndrome
- hypoplastic left heart syndrome (postulated), CHCHD3,6-related
- hypotonia, ataxia, and delayed development syndrome
- hypoxia adaptation and chronic mountain sickness
- ichthyosis, Dmel_osy model
- IMAGe syndrome
- immune and hematological syndromes, CDC42-related
- inclusion body myopathy with Paget disease of bone and frontotemporal dementia
- infantile cerebellar-retinal degeneration
- infection by eukaryotic pathogens
- infection by prokaryotic pathogens
- infection by viral pathogens
- inflammatory bowel disease
- inflammatory bowel disease, tight/septate junction defect
- insulin pathway effects, BMP/TGFB-related
- insulin pathway effects, decretin-related
- insulin pathway effects, FMR1-related
- insulin pathway effects, IDE-related
- insulin pathway effects, MIR137/PTPN1,2-related
- insulin pathway effects, MYORG-related
- insulin pathway effects, NUDT-related
- insulin pathway effects, PIK3C-related
- insulin pathway effects, RHEB-related
- insulin pathway effects, RPS6KB-related
- insulin pathway effects, SIRT1-related
- insulin pathway effects, TMEM18-related
- insulin pathway effects, TRIB-related
- insulin resistance syndromes, INSR-related
- intellectual developmental disorder, BCL11A,B-related
- intellectual developmental disorder with abnormal behavior, microcephaly, and short stature
- intellectual developmental disorder with autistic features and language delay, with or without seizures
- intellectual developmental disorder with ocular anomalies and distinctive facial features
- intellectual developmental disorder with short stature and behavioral abnormalities
- intellectual developmental disorder, X-linked, syndromic, Pilorge type
- intellectual developmental disorders, SMARCA2,4-related
- intellectual disability, autosomal dominant
- Coffin-Siris syndrome
- DYRK1A-related intellectual disability syndrome
- GAND syndrome
- intellectual developmental disorders, SMARCA2,4-related
- intellectual disability, autosomal dominant 21
- intellectual disability, autosomal dominant 48
- intellectual disability, autosomal dominant 55, with seizures
- intellectual disability, autosomal dominant 75
- intellectual disability, autosomal dominant, CAMK2-related
- intellectual disability (postulated), UPF1-related
- intellectual disability, syndromic, autosomal dominant, ZMYND8-related
- Kleefstra syndrome 1
- Koolen-De Vries syndrome
- Luo-Schoch-Yamamoto syndrome
- NESCAV syndrome
- neurodevelopmental disorder with hypotonia, speech delay, and dysmorphic facies
- intellectual disability, autosomal recessive
- intellectual disability, autosomal recessive 2
- intellectual disability, autosomal recessive 3
- intellectual disability, autosomal recessive 5
- intellectual disability, autosomal recessive 37
- intellectual disability, autosomal recessive 46
- intellectual disability, autosomal recessive 56
- intellectual disability, autosomal recessive 65
- intellectual disability, autosomal recessive 71
- intellectual disability, syndromic, autosomal recessive 82
- intellectual disability, syndromic, with renal and cardiac dysfunction, ADD3-KAT2B-related
- intellectual disability, BRWD-related
- intellectual disability, KDM5-related
- intellectual disability, syndromic, autosomal dominant, ZMYND8-related
- intellectual disability, X-linked, nonsyndromic
- intellectual disability, X-linked, syndromic
- fragile X syndrome
- intellectual developmental disorder, X-linked, syndromic, Billuart type
- intellectual disability, X-linked, CASK-related
- intellectual disability, X-linked, syndromic 13
- intellectual disability, X-linked, syndromic 34
- intellectual disability, X-linked, syndromic, Claes-Jensen type
- intellectual disability, X-linked, syndromic, Hedera type
- intellectual disability, X-linked, syndromic, Lubs type
- intellectual disability, X-linked, syndromic, Nascimento type
- intellectual disability, X-linked, syndromic, Snyder-Robinson type
- intellectual disability, X-linked, syndromic, Turner type
- Renpenning syndrome 1
- intellectual disability (postulated), BOD1-related
- intellectual disability (postulated), GPM6A-related
- intestinal dysfunction, RET-related
- intrauterine growth restriction, symmetrical, insulin-signaling-related
- juvenile myelomonocytic leukemia
- juvenile polyposis syndrome, TGF-beta/BMP signaling pathway
- kidney disease (fly models overview)
- branchiootorenal spectrum disorders, EYA1-related
- cystic renal dysplasia, susceptibility to
- Dent disease 1
- focal segmental glomerulosclerosis
- Galloway-Mowat syndrome 3
- high-fat diet, kidney disease
- high-sugar diet, nephropathy
- intellectual disability, syndromic, with renal and cardiac dysfunction, ADD3-KAT2B-related
- kidney disease, PAN-induced
- kidney disease (postulated), AMN-related
- kidney disease (postulated), CDC42-related
- kidney disease (postulated), CUBN-related
- kidney disease (postulated), NFATC1-related
- kidney disease (postulated), PALS1-related
- kidney disease (postulated), RGS14-related
- kidney disease (postulated), SRC-kinase-related
- kidney stone disease, chemically-induced
- kidney stone disease, V-ATPase models
- nephrotic syndrome
- nephrotic syndrome, KANK-related
- nephrotic syndrome, KIRREL-related
- nephrotic syndrome, type 1
- nephrotic syndrome, type 2
- nephrotic syndrome, type 9
- nephrotic syndrome, type 12
- nephrotic syndrome, type 14
- nephrotic syndrome, type 19
- nephrotic syndrome, type 20
- nephrotic syndrome, type 23
- nephrotic syndrome related to coenzyme Q deficiency
- nephrotic syndrome (postulated), GAPVD1-related
- nephrotic syndrome (postulated), stomatin-related
- polycystic kidney disease
- renal fibrosis, steroid-induced
- xanthinuria, type I
- Kleefstra syndrome
- Kohlschutter-Tonz syndrome
- Koolen-De Vries syndrome
- Kufor-Rakeb syndrome (PARK9)
- L1 syndrome
- LAMB1-related leukoencephalopathy and lissencephaly
- laminopathies
- Leber congenital amaurosis
- Leber hereditary optic neuropathy
- Leigh syndrome
- Leishmania species infection
- leptin deficiency or dysfunction
- leukodystrophy, hypomyelinating
- leukodystrophy, hypomyelinating, 5
- leukodystrophy, hypomyelinating, 18
- leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy
- leukodystrophy, demyelinating, adult-onset, autosomal dominant
- leukodystrophy with ataxia and sensorineural deafness
- Lewy body dementia, SNCA-related
- Lewy body dementia, susceptibility to, GBA1-related
- Li-Fraumeni syndrome 1
- lipodystrophy, congenital generalized
- lipodystrophy, familial partial
- lipotoxic cardiomyopathy, ceramide/sphingolipid-related
- lissencephaly
- Listeria monocytogenes infection
- liver disease (fly models overview)
- long QT syndrome
- long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
- Lowe oculocerebrorenal syndrome
- lung cancer, adenocarcinoma, KIF5B-RET fusion
- lung cancer, RAS-PTEN-related
- Luo-Schoch-Yamamoto syndrome
- lysosomal storage disorder (postulated), SPNS-related
- Machado-Joseph disease (SCA3)
- macrocephaly-autism syndrome
- macular retinal dystrophy 1, North Carolina type
- maple syrup urine disease, type II
- maturity-onset diabetes of the young
- megaloblastic anemia 1
- Meier-Gorlin syndrome
- Menkes disease
- MEPAN syndrome
- metabolic dysfunction-associated steatotic liver disease
- microcephalic primordial dwarfism
- microcephaly, epilepsy, and diabetes syndrome 1
- microcephaly, primary
- microcephaly 1, primary, autosomal recessive
- microcephaly 2, primary, autosomal recessive
- microcephaly 5, primary, autosomal recessive
- microcephaly 16, primary, autosomal recessive
- microcephaly 17, primary, autosomal recessive
- microcephaly 18, primary, autosomal dominant
- microcephaly, centrosome-SAC dysfunction
- microcephaly, condensin subunit insufficiency
- microcephaly, Zika virus-related
- migraine, familial hemiplegic 1
- migraine, familial hemiplegic 2
- mirror movements 1
- Mitchell syndrome
- mitochondrial complex I deficiency, nuclear type
- mitochondrial complex I disorders, MT-ND2-related
- mitochondrial complex II deficiency, nuclear type
- mitochondrial complex II deficiency (postulated), SDHAF4-related
- mitochondrial complex III deficiency, nuclear type
- mitochondrial complex IV deficiency, nuclear type
- mitochondrial complex IV deficiency, nuclear type 1
- mitochondrial complex IV deficiency, nuclear type, SCO1,2-related
- mitochondrial complex IV deficiency, nuclear type 5
- mitochondrial complex IV deficiency, nuclear type 17
- mitochondrial complex IV disorder (postulated), CEP89-related
- mitochondrial complex IV dysfunction, general model
- spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3
- mitochondrial complex IV disorders, MT-CO1-related
- mitochondrial complex V (ATP synthase) deficiency, nuclear type
- mitochondrial complex V disorders, MT-ATP6-related
- mitochondrial disease with seizure-sensitivity and hearing loss (postulated), MRPS12-related
- mitochondrial disease and seizure sensitivity, SLC25A4(ANT1)-related
- mitochondrial disorders, VDAC-related
- mitochondrial DNA depletion syndrome
- mitochondrial ECHS1 deficiency
- mitochondrial pyruvate carrier deficiency
- mitochondrial respiratory complex disease, mitochondrial types
- mitochondrial trifunctional protein deficiency
- motor neuron disease (postulated), WRAP53-related
- motor neuron disease (postulated), VPS54-related
- mtDNA polymerase disorders, POLG-related
- mucolipidosis IV
- mucopolysaccharidoses
- multiple acyl-CoA dehydrogenase deficiency
- multiple endocrine neoplasia
- multiple myeloma, DIS3-related
- multiple sulfatase deficiency
- multisystemic disorder with developmental delay, skeletal, cardiac, and neurological abnormalities, TMEM208-related
- muscle and aortic defects, ARIH1-related
- muscular dystrophy
- fascioscapulohumeral muscular dystrophy, DUX4-related
- fascioscapulohumeral muscular dystrophy, FRG1-related
- muscular dystrophy, DAG1-related
- muscular dystrophy, dystrophin-related
- muscular dystrophy, Emery-Dreifuss
- muscular dystrophy, lamin-related
- muscular dystrophy, limb-girdle, autosomal dominant
- muscular dystrophy, limb-girdle, autosomal recessive
- muscular dystrophy-dystroglycanopathy (limb-girdle), type C1
- muscular dystrophy-dystroglycanopathy (limb-girdle), type C2
- muscular dystrophy-dystroglycanopathy (limb-girdle), type C9
- muscular dystrophy, limb-girdle, autosomal recessive 29
- muscular dystrophy, limb-girdle, type 2C
- muscular dystrophy, limb-girdle, type 2F
- muscular dystrophy, limb-girdle, type 2H
- muscular dystrophy, limb-girdle, type 2Z
- muscular dystrophy, POMT1-related
- muscular dystrophy, POMT2-related
- muscular dystrophy, sarcoglycan-related D,G
- muscular dystrophy, TRIM-gene-related
- muscular dystrophy-dystroglycanopathy
- myotonic dystrophy
- oculopharyngeal muscular dystrophy
- Mycobacterium species infection
- myeloproliferative disorders, JAK2-related
- MYH9-related disorder
- myoclonic-atonic epilepsy
- myopathy, congenital
- myopathy, distal, 1
- myopathy, distal, 4
- myopathy, FLNC-related
- myopathy, lactic acidosis, and sideroblastic anemia
- myopathy, miR-9-related
- myopathy, MYH-class-II-related
- myopathy, myofibrillar
- myopathy with extrapyramidal signs
- myopathy, statin-induced
- myopathy with rimmed vacuoles, TARDBP-related
- myotonic dystrophy
- nemaline myopathy
- nephrotic syndrome
- nephrotic syndrome, KANK-related
- nephrotic syndrome, KIRREL-related
- nephrotic syndrome, type 1
- nephrotic syndrome, type 2
- nephrotic syndrome, type 9
- nephrotic syndrome, type 12
- nephrotic syndrome, type 14
- nephrotic syndrome, type 19
- nephrotic syndrome, type 20
- nephrotic syndrome, type 23
- nephrotic syndrome related to coenzyme Q deficiency
- nephrotic syndrome (postulated), GAPVD1-related
- nephrotic syndrome (postulated), stomatin-related
- NESCAV syndrome
- Nestor-Guillermo progeria syndrome
- neural and muscular diseases (fly methods and biology)
- neural tube defect, VANGL1/2-related
- neuroblastoma, susceptibility to, 3
- neurodegeneration, activity dependent, DEGS-related
- neurodegeneration, childhood-onset, with brain atrophy
- neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures
- neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset
- neurodegeneration with brain iron accumulation
- neurodegenerative disease, ACOX1-related
- neurodegenerative disease, AFG3L2-related
- neurodegenerative disease, arcRNA-related
- neurodegenerative disease, C19orf12-related
- neurodegenerative disease, CHCHD2,10-related
- neurodegenerative disease, FIG4-related
- neurodegenerative disease, KIF5-related
- neurodegenerative disease, lysosomal-autophagy pathway, MITF-TFE-related
- neurodegenerative disease, miRNA-mediated glutamate receptor dysregulation in glia
- neurodegenerative disease, MME-related
- neurodegenerative disease, NRDC-related
- neurodegenerative disease, PLA2G6-related
- neurodegenerative disease, PNPLA6-related
- neurodegenerative disease, SLC25A39,40-related
- neurodegenerative disease, SQSTM1-related
- neurodegenerative disease, UBQLN-related
- neurodegenerative disease, VPS13-related
- neurodegenerative disease of CoA-mtACP-PDH pathway, NDUFAB1 model
- neurodegenerative disease (postulated), ABCG-related
- neurodegenerative disease (postulated), AMPK-related
- neurodegenerative disease (postulated), MIR137-related
- neurodegenerative disease (postulated), NPLOC4-related
- neurodegenerative disease (postulated), SLC17A/VGLUT-related
- neurodegenerative disease, susceptibility to, SOX5-related
- neurodegenerative disorders, ATP13A2-related
- neurodevelopmental disorder, CDKL2-related
- neurodevelopmental disorder, EZH1-related
- neurodevelopmental disorder, GTPBP1/GTPBP2-related
- neurodevelopmental disorder, MRTFB-related
- neurodevelopmental disorder, neural stem cell dedifferentiation
- neurodevelopmental disorder, PRPF19-related
- neurodevelopmental disorder, SLK-related
- neurodevelopmental disorder, UNC79-related
- neurodevelopmental disorder (postulated), CDKL1-related
- neurodevelopmental disorder (postulated), DROSHA-related
- neurodevelopmental disorder (postulated), WDR5-related
- neurodevelopmental disorder with behavioral abnormalities and childhood onset spastic paraplegia
- neurodevelopmental disorder with cerebellar atrophy and motor dysfunction
- neurodevelopmental disorder with cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay
- neurodevelopmental disorder with developmental delay, hypotonia, and impaired language
- neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities
- neurodevelopmental disorder with dysmorphic facies and thin corpus callosum
- neurodevelopmental disorder with eye movement abnormalities and ataxia
- neurodevelopmental disorder with hypotonia and speech delay, with or without seizures
- neurodevelopmental disorder with hypotonia, speech delay, and dysmorphic facies
- neurodevelopmental disorder with intellectual disability, hypotonia, impaired speech, and dysmorphic facies
- neurodevelopmental disorder with language delay and seizures
- neurodevelopmental disorder with microcephaly, RBBP5-related
- neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities
- neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity
- neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy
- neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities
- neurodevelopmental disorder with or without autism or seizures
- neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures
- neurodevelopmental disorder with severe developmental delay, intellectual disability, and behavioral abnormalities, CYFIP1-related
- neurodevelopmental disorder with spasticity and poor growth
- neurodevelopmental disorder with spasticity, thin corpus callosum, and decreased brain white matter
- neurodevelopmental disorder with speech impairment and dysmorphic facies
- neurodevelopmental disorders, FAT4-related
- neurodevelopmental disorders, MECP2-related
- neurodevelopmental disorders (postulated), TAOK-related
- neurodevelopmental disorders, susceptibility to (postulated), MIR22-related
- neurodevelopmental disorders, susceptibility to (postulated), RBFOX-related
- neurodevelopmental disorders, WDR81-related
- neurodevelopmental syndrome with mild facial dysmorphia, SMARCA5-related
- neurofibromatosis, type 1
- neurological and neurodegenerative disease, ubiquitin pathways
- neurological disorder with hypotonia, hyper-reflexia, ataxia, dystonia and white matter abnormalities, TOMM70-related
- neurological disorder with or without progressive infantile liver disease
- neurological disorders, ATP6AP2-related
- neurological disorders, ATPalpha-related
- neurological disorders, GNAO1-related
- neurological disorders, MPV17-related
- neurological disorders, TMEM63-related
- neuromuscular disease, ATP2A-related
- neuromuscular disease, DCTN1-related
- neuromuscular disease, JPH-related
- neuromuscular disease, MARS2-related
- neuromuscular disease, MICU1-related
- neuromuscular diseases, TRPV4-related
- neuronal ceroid lipofuscinosis
- neuronal intranuclear inclusion disease
- neuronal necrosis, calcium overload model
- neuronopathy, distal hereditary motor
- neuronopathy, distal hereditary motor, autosomal dominant 2
- neuronopathy, distal hereditary motor, autosomal dominant 3
- neuronopathy, distal hereditary motor, autosomal dominant 4
- neuronopathy, distal hereditary motor, autosomal dominant 5
- neuronopathy, distal hereditary motor, autosomal dominant 8
- neuronopathy, distal hereditary motor, autosomal dominant 14
- neuronopathy, distal hereditary motor, autosomal recessive 8
- neuronopathy, distal hereditary motor, X-linked
- neuronopathy, HSPB8-related
- neurooculocardiogenitourinary syndrome
- neuropathy, ataxia, and retinitis pigmentosa
- neuropathy, hereditary sensory and autonomic
- neuropathy, hereditary motor and sensory, type IIC
- neuropathy, hereditary motor and sensory, type VIA
- neuropathy, hereditary motor and sensory, type VIB
- NFIA-related disorder
- Niemann-Pick disease
- night blindness, congenital stationary
- Nijmegen breakage syndrome
- Nil-Deshwar neurodevelopmental syndrome
- nociceptive pain sensitization, injury-induced
- Noonan syndrome
- Noonan syndrome with multiple lentigines
- NSD1 duplication syndrome
- nystagmus, congenital
- obesity, susceptibility to (fly models overview)
- age-dependent ectopic fat accumulation, HDAC6-related
- diabetes/obesity, impact of parental disease
- high-fat diet, obesity
- high-sugar diet, obesity
- insulin signaling, regulation of fat storage, Drosophila fat body model
- leptin deficiency or dysfunction
- obesity and behavioral phenotypes (postulated), ETV5-related
- obesity and cardiomyocyte regulation of systemic lipid levels, APOB-related
- obesity and cardiomyocyte regulation of systemic lipid levels, MTTP-related
- obesity and cardiomyocyte regulation of systemic lipid levels, role of SNAIL TF genes
- obesity and diabetes type 1, susceptibility to (postulated), ITPR-related
- obesity and metabolic disorder, starvation-resistant populations
- obesity and metabolic disorder, susceptibility to (postulated), MIR33-related
- obesity model, activation of Taotie neurons
- obesity model, prolonged larval stage
- obesity, body-fat sensor mechanisms, semaphorin-related
- obesity, susceptibility to, adipokinetic hormone model
- obesity, susceptibility to, TFAP2B-KCTD15-CCK regulation of feeding behavior
- obesity, susceptibility to (postulated), ABHD4/5-related
- obesity, susceptibility to (postulated), ceramide/sphingolipid-related
- obesity, susceptibility to (postulated), CAPN8-related
- obesity, susceptibility to (postulated), CORO7-related
- obesity, susceptibility to (postulated), DNAH10-related
- obesity, susceptibility to (postulated), FLII-related
- obesity, susceptibility to (postulated), hedgehog signaling pathway
- obesity, susceptibility to (postulated), Hippo signaling pathway
- obesity, susceptibility to (postulated), MED12-related
- obesity, susceptibility to (postulated), MED13-related
- obesity, susceptibility to (postulated), neurotensin-related
- obesity, susceptibility to (postulated), NKX6-3-related
- obesity, susceptibility to (postulated), PLIN-related
- obesity, susceptibility to (postulated), PLXND1-related
- obesity, susceptibility to (postulated), PNPLA/ATGL-related
- obesity, susceptibility to (postulated), SDK1-related
- obesity, susceptibility to (postulated), SEC16B-related
- obesity, susceptibility to (postulated), serotonin class 2 receptor(s)
- obesity, susceptibility to (postulated), SNCAIP-related
- obesity, susceptibility to (postulated), SPEN-related
- obesity, susceptibility to (postulated), STIM1-related
- obesity, susceptibility to (postulated), THADA-related
- obesity, susceptibility to (postulated), WDTC1-related
- obesity, susceptibility to (postulated), Wnt signaling pathway
- occipital horn syndrome
- oculopharyngeal muscular dystrophy
- Oliver-McFarlane syndrome
- operant self-learning disorders, FOXP-related
- optic atrophy
- organophosphate-induced delayed neuropathy
- ovarian carcinoma, RAS-PKRC-related
- ovarian dysgenesis
- oxoglutarate dehydrogenase deficiency
- Pan-Chung-Bellen syndrome
- pancreatic carcinoma, multigenic
- pancreatic islet amyloidosis, IAPP-related
- panhypopituitarism, X-linked, with or without intellectual disability
- Parkinson disease
- Parkinson disease 1
- Parkinson disease 2, early-onset
- Parkinson disease 4
- Parkinson disease 5, susceptibility to
- Parkinson disease 6, early-onset
- Parkinson disease 7, early-onset
- Parkinson disease 8
- Parkinson disease 11, susceptibility to
- Parkinson disease 13, susceptibility to
- Parkinson disease 14
- Parkinson disease 15, early-onset
- Parkinson disease 16 (postulated), RAB29-related
- Parkinson disease 17
- Parkinson disease 19A/B, early-onset
- Parkinson disease 20, early-onset
- Parkinson disease 22
- Parkinson disease 23, early-onset
- Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development
- Parkinson disease, early-onset (postulated), SGIP1-related
- Parkinson disease (postulated), BOK-related
- Parkinson disease (postulated), DNAJC13-related
- Parkinson disease (postulated), FOXO-related
- Parkinson disease (postulated), GPR37-related
- Parkinson disease (postulated), IMMT-related
- Parkinson disease (postulated), NSF-related
- Parkinson disease (postulated), NUS1-related
- Parkinson disease (postulated), PAK4-related
- Parkinson disease (postulated), PGC-1-related
- Parkinson disease (postulated), SNCAIP-related
- Parkinson disease (postulated), TMEM230-related
- Parkinson disease (postulated), TPPP-related
- Parkinson disease (postulated), ZNF746-related
- Parkinson disease, susceptibility plus toxin exposure
- Parkinson disease, susceptibility to, AP2M1-related
- Parkinson disease, susceptibility to, auxilin-related
- Parkinson disease, susceptibility to, GBA1-related
- Parkinson disease, susceptibility to, SH3GL2-related
- Parkinson disease, susceptibility to, SREBF1-related
- parkinsonism with polyneuropathy
- Waisman syndrome
- Parkinson disease, iron overload
- Parkinson-like disease, BPA-induced
- Parkinson-like disease, metal toxicity
- Parkinson-like disease, MPP/MPTP-induced
- Parkinson-like disease, toxin-induced
- Parkinson-like disease (postulated), HSPA9-related
- Parkinson-like model, Dmel_Fer2
- Parkinson-like model, PGK-related
- Parkinson-like model, proteasome-related
- Parkinson-like model, RHOT/Miro-related
- parkinsonism-dystonia, infantile 1
- paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy
- Paul-Chao neurodevelopmental syndrome
- Perlman syndrome
- peripheral neuropathy, drug-induced
- peroxisomal acyl-CoA oxidase deficiency
- peroxisome biogenesis disorder
- Perry syndrome
- persistent alcohol cue memory
- phenylketonuria
- Pick disease
- PIGA-related seizure disorders
- pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
- Pitt-Hopkins syndrome
- Pitt-Hopkins-like syndrome 1
- Pitt-Hopkins-like syndrome 2
- pituitary adenoma 1, multiple types
- polyalanine diseases
- polycystic kidney disease
- polyglutamine diseases
- polyglutamine diseases, polyQ models
- pontocerebellar hypoplasia
- Popov-Chang syndrome
- porphyria-like (postulated), GBE1-related
- primary ovarian insufficiency
- prion diseases
- progeroid syndrome
- progressive external ophthalmoplegia with mtDNA deletions
- progressive supranuclear palsy 1
- proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome
- prostate cancer
- pseudohypoaldosteronism, type II
- Pseudomonas aeruginosa infection
- purine recycling disorders
- pyridoxamine 5'-phosphate oxidase deficiency
- pyruvate dehydrogenase complex deficiency
- RASopathies, MAP2K1,2-related
- reducing body myopathy 1A
- renal fibrosis, steroid-induced
- Renpenning syndrome 1
- restless legs syndrome
- retinal disease, inherited (fly models overview)
- retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
- Rett syndrome
- rhabdoid tumor predisposition syndrome 1
- rhabdomyosarcoma 2, PAX3-FOXO1 fusion
- rhabdomyosarcoma 2, PAX7-FOXO1 fusion
- riboflavin transporter deficiency neuronopathy
- RNA repeat diseases
- Robinow syndrome, autosomal dominant 2
- RYBP-related syndrome
- Salmonella species infection
- Sandestig-Stefanova syndrome
- SARS-CoV-1,2 viral infection
- SATB2-associated syndrome
- SREBF2-related syndrome with dermatologic, neurologic, and skeletal defects
- scapuloperoneal spinal muscular atrophy
- schizophrenia, susceptibility to
- Schimke immuno-osseous dysplasia
- schwannomatosis, vestibular
- Seckel syndrome 9
- seizures, benign familial infantile
- seizure-sensitive (postulated), ETNK-related
- seizure-sensitive (postulated), SLC12A1-3-related
- seizure-sensitive (postulated), SLC24A-related
- seizure-sensitive, potassium channel defects (eag, Sh model)
- seizure-sensitive, potassium channel defects, KCNT1-2-related
- seizure-sensitive (postulated), UBE3A-related
- seizure sensitive/resistant (postulated), PRKG1-related
- seizure sensitivity, disruption during critical developmental period
- seizure-sensitivity model, Dmel_jus
- sensory ataxic neuropathy, dysarthria, and ophthalmoparesis
- Serratia marcescens infection
- SETD2-related diseases
- short stature, hearing loss, retinitis pigmentosa, and distinctive facies
- Shwachman-Diamond syndrome 1
- Siddiqi syndrome
- Sindbis virus infection
- SLC5A6-related disorders
- Sotos syndrome 1
- spastic ataxia
- spastic paraplegia
- spinal muscular atrophy
- motor neuron disease (postulated), WRAP53-related
- neuronopathy, distal hereditary motor, X-linked
- spinal and bulbar muscular atrophy, X-linked 1
- spinal muscular atrophy, Jokela type
- spinal muscular atrophy, late onset, Finkel type
- spinal muscular atrophy, lower extremity-predominant 1
- spinal muscular atrophy, lower extremity-predominant 2
- spinal muscular atrophy, SMN-related
- spinocerebellar ataxia, autosomal dominant
- spinocerebellar ataxia, autosomal recessive
- ataxia-oculomotor apraxia 1
- ataxia-telangiectasia
- ataxia-telangiectasia-like disorder 1
- neurodevelopmental disorder with spasticity and poor growth
- spinocerebellar ataxia, autosomal recessive 4
- spinocerebellar ataxia, autosomal recessive 13
- spinocerebellar ataxia, autosomal recessive 14
- spinocerebellar ataxia, autosomal recessive 21
- spinocerebellar ataxia, autosomal recessive 24 (postulated)
- spinocerebellar ataxia, autosomal recessive 25 (postulated)
- spinocerebellar ataxia, autosomal recessive 27
- spinocerebellar ataxia, autosomal recessive 32
- spinocerebellar ataxia, autosomal recessive (postulated), UFM1-related
- spinocerebellar ataxia, autosomal recessive, with axonal neuropathy
- spondyloarthropathy, susceptibility to
- Staphylococcus aureus infection
- Stolerman neurodevelopmental syndrome
- Streptococcus species infection
- striatonigral degeneration, infantile, mitochondrial
- sulfite oxidase deficiency, isolated
- synaptic dysfunction, KIF1-related
- synaptic transmission defects, IDH3A-related
- TANGO2-related metabolic encephalopathy and arrhythmias
- tauopathies
- TBC1D24-related disorders
- thyroid carcinoma, familial medullary
- thyroid carcinoma, nonmedullary
- Townes-Brocks syndrome
- toxicity studies (fly models overview)
- traumatic brain injury and chronic traumatic encephalopathy
- trichothiodystrophy
- triosephosphate isomerase deficiency
- tuberous sclerosis complex
- type IV collagenopathies
- ulcerative colitis-like, chemically induced
- ulnar-mammary syndrome
- uric acid nephrolithiasis, Dmel_CG10939 model
- Usher syndrome
- Usher syndrome, deafness, MYO7A-related
- Van Maldergem syndrome 2
- vertebral anomalies and variable endocrine and T-cell dysfunction
- vertebral hypersegmentation and orofacial anomalies
- Vibrio cholerae infection
- Vici syndrome
- viral infection, susceptibility to (postulated), EHMT-related
- visceral myopathy (postulated), MSTO1-related
- visual impairment and progressive phthisis bulbi
- Vissers-Bodmer syndrome
- von Hippel-Lindau syndrome
- Waisman syndrome
- Wallerian degeneration
- Warburg micro syndrome
- Werner syndrome
- WFS1-related disorders
- White-Sutton syndrome
- Williams-Beuren syndrome
- Wilson disease
- Wolfram syndrome 1
- Wolfram syndrome 2
- xanthinuria, type I
- xeroderma pigmentosum
- Yoon-Bellen neurodevelopmental syndrome
- Yunis-Varon syndrome
